Quoin Pharmaceuticals Ltd DRC (QNRX)

Currency in USD
6.6950
-0.1250(-1.83%)
Closed·
After Hours
6.7000+0.0050(+0.07%)
·
QNRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
QNRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.62506.8000
52 wk Range
5.010054.9500
Key Statistics
Prev. Close
6.695
Open
6.8
Day's Range
6.625-6.8
52 wk Range
5.01-54.95
Volume
2.42K
Average Volume (3m)
172.2K
1-Year Change
-67.55%
Book Value / Share
10.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
QNRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
150.0001
Upside
+2,140.48%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Quoin Pharmaceuticals Ltd DRC Company Profile

Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.

Compare QNRX to Peers and Sector

Metrics to compare
QNRX
Peers
Sector
Relationship
P/E Ratio
−0.4x−5.7x−0.5x
PEG Ratio
0.00−0.110.00
Price/Book
0.7x3.2x2.6x
Price / LTM Sales
-10.3x3.3x
Upside (Analyst Target)
-176.9%43.5%
Fair Value Upside
Unlock−4.0%6.3%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 150.0001
(+2,140.48% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-6.50 / -0.52
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

QNRX Income Statement

People Also Watch

5.71
REPL
-24.87%
17.10
SRPT
+7.48%
9.8100
CYCC
+0.93%
1.00
KLTO
+8.70%
0.046
NCNA
+17.90%

FAQ

What Stock Exchange Does Quoin Pharmaceuticals DRC Trade On?

Quoin Pharmaceuticals DRC is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Quoin Pharmaceuticals DRC?

The stock symbol for Quoin Pharmaceuticals DRC is "QNRX."

What Is the Quoin Pharmaceuticals DRC Market Cap?

As of today, Quoin Pharmaceuticals DRC market cap is 3.94M.

What Is Quoin Pharmaceuticals DRC's Earnings Per Share (TTM)?

The Quoin Pharmaceuticals DRC EPS (TTM) is -39.35.

From a Technical Analysis Perspective, Is QNRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Quoin Pharmaceuticals DRC Stock Split?

Quoin Pharmaceuticals DRC has split 3 times.

How Many Employees Does Quoin Pharmaceuticals DRC Have?

Quoin Pharmaceuticals DRC has 4 employees.

What is the current trading status of Quoin Pharmaceuticals DRC (QNRX)?

As of 05 Aug 2025, Quoin Pharmaceuticals DRC (QNRX) is trading at a price of 6.70, with a previous close of 6.70. The stock has fluctuated within a day range of 6.63 to 6.80, while its 52-week range spans from 5.01 to 54.95.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.